Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25053003 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Marta Moreno-Torres und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unidad Mixta de Hepatología Experimental, Instituto de Investigación Sanitaria del Hospital La Fe (IIS La Fe), 46026 Valencia, Spain. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Cholestasis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación, Conselleria de Educación, Universidades y Empleo de la Generalitat Valenciana, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Drug-induced liver injury (DILI) is a serious adverse hepatic event presenting diagnostic and prognostic challenges. The clinical categorization of DILI into hepatocellular, cholestatic, or mixed phenotype is based on serum alanine aminotransferase (ALT) and alkaline phosphatase (ALP) values; however, this classification may not capture the full spectrum of DILI subtypes. With this aim, we explored the utility of assessing changes in the plasma metabolomic profiles of 79 DILI patients assessed by the RUCAM (Roussel Uclaf Causality Assessment Method) score to better characterize this condition and compare results obtained with the standard clinical characterization. Through the identification of various metabolites in the plasma (including free and conjugated bile acids and glycerophospholipids), and the integration of this information into predictive models, we were able to evaluate the extent of the hepatocellular or cholestatic phenotype and to assign a numeric value with the contribution of each specific DILI sub-phenotype into the patient’s general condition. Additionally, our results showed that metabolomic analysis enabled the monitoring of DILI variability responses to the same drug, the transitions between sub-phenotypes during disease progression, and identified a spectrum of residual DILI metabolic features, which can be overlooked using standard clinical diagnosis during patient follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidad Mixta de Hepatología Experimental, Instituto de Investigación Sanitaria del Hospital La Fe (IIS La Fe), 46026 Valencia, Spain.
- Departamento de Bioquímica y Biología Molecular, Facultad de Medicina y Odontología, Universidad de Valencia, 46010 Valencia, Spain.
- Centro de Investigación Biomédica En Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Metabolomics and Bioanalysis, Leitat Technological Center (LEITAT,) 46026 Valencia, Spain.
ORCID-Profile: Marta Moreno-Torres, Guillermo Quintás, Ramiro Jover, José V Castell
Förderung
- Ministerio de Ciencia e Innovación
- Conselleria de Educación, Universidades y Empleo de la Generalitat Valenciana
- Instituto de Salud Carlos III
- FP7-HEALTH-2013-INNOVATION-1
- Eutoxrisk
- MICIU/AEI/10.13039/501100011033
- European Union NextGenerationEU/PRTR
- FEDER, UE
Zitieren
APA
Moreno-Torres, M., Quintás, G., Martínez-Sena, T., Jover, R., & Castell, J. V. (2024). Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25053003
Vancouver
Moreno-Torres M, Quintás G, Martínez-Sena T, Jover R, Castell JV. Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25053003
BibTeX
@article{MorenoTorres2024,
author = {Moreno-Torres, Marta and Quintás, Guillermo and Martínez-Sena, Teresa and Jover, Ramiro and Castell, José V},
title = {Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25053003}
}
EUVIMED